| Title |
Colony‐stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia
|
|---|---|
| Published in |
Cochrane database of systematic reviews, June 2012
|
| DOI | 10.1002/14651858.cd008238.pub3 |
| Pubmed ID | |
| Authors |
Ronit Gurion, Yulia Belnik‐Plitman, Anat Gafter‐Gvili, Mical Paul, Liat Vidal, Isaac Ben‐Bassat, Ofer Shpilberg, Pia Raanani |
| Abstract |
Acute myelogenous leukemia (AML) is a fatal bone marrow cancer. Colony-stimulating factors (CSFs) are frequently administered during and after chemotherapy to reduce complications. However, their safety with regard to disease-related outcomes and survival in AML is unclear. Therefore, we performed a systematic review and meta-analysis to evaluate the impact of CSFs on patient outcomes, including survival. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 1 | 33% |
| Spain | 1 | 33% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 118 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | <1% |
| Unknown | 117 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 17 | 14% |
| Student > Bachelor | 15 | 13% |
| Other | 13 | 11% |
| Student > Doctoral Student | 10 | 8% |
| Student > Postgraduate | 10 | 8% |
| Other | 23 | 19% |
| Unknown | 30 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 57 | 48% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 6% |
| Nursing and Health Professions | 6 | 5% |
| Agricultural and Biological Sciences | 4 | 3% |
| Biochemistry, Genetics and Molecular Biology | 3 | 3% |
| Other | 8 | 7% |
| Unknown | 33 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 July 2012.
All research outputs
#15,799,182
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#10,126
of 11,499 outputs
Outputs of similar age
#108,979
of 181,239 outputs
Outputs of similar age from Cochrane database of systematic reviews
#139
of 175 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 11th percentile – i.e., 11% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 181,239 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 175 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.